Kathy Freeman

“It’s hard to find participants for oncology and rare diseases. They have strong relationships with their specialists, and specialists are more likely to provide access to their patients if they can stay within their practice to participate in a clinical study. MedVector’s innovative platform provides the key to unlock access to millions of patients.”